Synthetic cannabinoid presentations decline following ban

Drug and Alcohol Review

Volumn 35, Issue 2, 2016, Pages E3-E4

  Christie, Grant ^a   Macfarlane, Vicki ^b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Cannabis; Harm reduction; Substance related disorder; Substance withdrawal syndrome; Synthetic cannabinoid

Indexed keywords

CANNABINOID; STREET DRUG;

DRUG LEGISLATION; ECONOMICS; HUMAN; LEGISLATION AND JURISPRUDENCE; NEW ZEALAND; SUBSTANCE WITHDRAWAL SYNDROME;

CANNABINOIDS; HUMANS; LEGISLATION, DRUG; NEW ZEALAND; STREET DRUGS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84949671960     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12352     Document Type: Letter

References (6)

1. MacFarlane V, Christie G. Synthetic cannabinoid withdrawal: a new demand on detoxification services. Drug Alcohol Rev 2015;34:147-153.
2. Ministry of Health. The Psychoactive Substances Act 2013. Available at: http://psychoactives.health.govt.nz/psychoactive-substances-act-2013 (accessed September 2015).
3. Brown R. If it's not true to label, then what are people taking? Matters of Substance, 2015. Available at: http://www.drugfoundation.org.nz/matters-of-substance/may-2015/not-true-to-label (accessed September 2015).
4. Winstock A. The Global Drug Survey 2014 findings, 2015 Available at: http://www.globaldrugsurvey.com/the-global-drug-survey-2014-findings (accessed September 2015).
5. Price C. Dry Times. Matters of Substance 2015. Available at: http://www.drugfoundation.org.nz/matters-of-substance/may-2015/dry-times (accessed September 2015).
6. Winstock A. What did we learn from GDS2015? An overview of our key findings, 2015. Available at: http://www.globaldrugsurvey.com/the-global-drug-survey-2015-findings (accessed September 2015).